Literature DB >> 23205284

A discriminant function model as an alternative method to spirometry for COPD screening in primary care settings in China.

Jiangyu Cui1, Yumin Zhou, Jia Tian, Xinwang Wang, Jingping Zheng, Nanshan Zhong, Pixin Ran.   

Abstract

OBJECTIVE: COPD is often underdiagnosed in a primary care setting where the spirometry is unavailable. This study was aimed to develop a simple, economical and applicable model for COPD screening in those settings.
METHODS: First we established a discriminant function model based on Bayes' Rule by stepwise discriminant analysis, using the data from 243 COPD patients and 112 non-COPD subjects from our COPD survey in urban and rural communities and local primary care settings in Guangdong Province, China. We then used this model to discriminate COPD in additional 150 subjects (50 non-COPD and 100 COPD ones) who had been recruited by the same methods as used to have established the model. All participants completed pre- and post-bronchodilator spirometry and questionnaires. COPD was diagnosed according to the Global Initiative for Chronic Obstructive Lung Disease criteria. The sensitivity and specificity of the discriminant function model was assessed.
RESULTS: THE ESTABLISHED DISCRIMINANT FUNCTION MODEL INCLUDED NINE VARIABLES: age, gender, smoking index, body mass index, occupational exposure, living environment, wheezing, cough and dyspnoea. The sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, accuracy and error rate of the function model to discriminate COPD were 89.00%, 82.00%, 4.94, 0.13, 86.66% and 13.34%, respectively. The accuracy and Kappa value of the function model to predict COPD stages were 70% and 0.61 (95% CI, 0.50 to 0.71).
CONCLUSIONS: This discriminant function model may be used for COPD screening in primary care settings in China as an alternative option instead of spirometry.

Entities:  

Keywords:  Bayes’ Rule; COPD; spirometry

Year:  2012        PMID: 23205284      PMCID: PMC3506808          DOI: 10.3978/j.issn.2072-1439.2012.11.06

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  42 in total

Review 1.  The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design.

Authors:  A Sonia Buist; William M Vollmer; Sean D Sullivan; Kevin B Weiss; Todd A Lee; Ana M B Menezes; Robert O Crapo; Robert L Jensen; Peter G J Burney
Journal:  COPD       Date:  2005-06       Impact factor: 2.409

2.  Evidence-based health policy--lessons from the Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

3.  Scoring system and clinical application of COPD diagnostic questionnaires.

Authors:  David B Price; David G Tinkelman; Robert J Nordyke; Sharon Isonaka; R J Halbert
Journal:  Chest       Date:  2006-06       Impact factor: 9.410

Review 4.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

5.  Symptom-based questionnaire for identifying COPD in smokers.

Authors:  David B Price; David G Tinkelman; R J Halbert; Robert J Nordyke; Sharon Isonaka; Dmitry Nonikov; Elizabeth F Juniper; Daryl Freeman; Thomas Hausen; Mark L Levy; Anders Ostrem; Thys van der Molen; Constant P van Schayck
Journal:  Respiration       Date:  2005-12-05       Impact factor: 3.580

6.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

7.  [Analysis of basic data of the study on prevention and treatment of COPD and chronic cor pulmonale].

Authors:  X Cheng; J Li; Z Zhang
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  1998-12

8.  The prevalence of COPD: using smoking rates to estimate disease frequency in the general population.

Authors:  P Stang; E Lydick; C Silberman; A Kempel; E T Keating
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

9.  Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China.

Authors:  Shengming Liu; Yumin Zhou; Xiaoping Wang; Dali Wang; Jiachun Lu; Jingping Zheng; Nanshan Zhong; Pixin Ran
Journal:  Thorax       Date:  2007-05-04       Impact factor: 9.139

10.  Environmental factors and hospitalisation for chronic obstructive pulmonary disease in a rural county of England.

Authors:  V Sauerzapf; A P Jones; J Cross
Journal:  J Epidemiol Community Health       Date:  2009-02-10       Impact factor: 3.710

View more
  4 in total

1.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

2.  The Construction of Primary Screening Model and Discriminant Model for Chronic Obstructive Pulmonary Disease in Northeast China.

Authors:  Xiaomeng Li; Yuhao Guo; Wenyang Li; Wei Wang; Fang Zhang; Shanqun Li
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-31

3.  Influences of Two FEV1 Reference Equations (GLI-2012 and GIRH-2017) on Airflow Limitation Classification Among COPD Patients.

Authors:  Dafei Wei; Qi Wang; Shasha Liu; Xiaowu Tan; Lin Chen; Rongfang Tu; Qing Liu; Yuanhang Jia; Sha Liu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-09-02

4.  The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019.

Authors:  Peng Yin; Jiayuan Wu; Lijun Wang; Chaole Luo; Lihuan Ouyang; Xiantong Tang; Jiangmei Liu; Yunning Liu; Jinlei Qi; Maigeng Zhou; Tianwen Lai
Journal:  Front Public Health       Date:  2022-06-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.